DK1687259T3 - Cyclopentylderivater - Google Patents

Cyclopentylderivater

Info

Publication number
DK1687259T3
DK1687259T3 DK04819587T DK04819587T DK1687259T3 DK 1687259 T3 DK1687259 T3 DK 1687259T3 DK 04819587 T DK04819587 T DK 04819587T DK 04819587 T DK04819587 T DK 04819587T DK 1687259 T3 DK1687259 T3 DK 1687259T3
Authority
DK
Denmark
Prior art keywords
alkyl
trifluoromethyl
hydroxy
optionally substituted
independently hydrogen
Prior art date
Application number
DK04819587T
Other languages
Danish (da)
English (en)
Inventor
Piero Melloni
David Cibele Maria Sabido
Alessandra Restivo
Roberto Forlani
Patricia Salvati
Original Assignee
Newron Pharm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newron Pharm Spa filed Critical Newron Pharm Spa
Application granted granted Critical
Publication of DK1687259T3 publication Critical patent/DK1687259T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Lubricants (AREA)
DK04819587T 2003-11-24 2004-11-12 Cyclopentylderivater DK1687259T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03027050A EP1533295A1 (en) 2003-11-24 2003-11-24 Cyclopentyl Derivatives
PCT/EP2004/012835 WO2005054178A1 (en) 2003-11-24 2004-11-12 Cyclopentyl derivatives

Publications (1)

Publication Number Publication Date
DK1687259T3 true DK1687259T3 (da) 2007-12-03

Family

ID=34429431

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04819587T DK1687259T3 (da) 2003-11-24 2004-11-12 Cyclopentylderivater

Country Status (22)

Country Link
US (1) US7265244B2 (zh)
EP (2) EP1533295A1 (zh)
JP (1) JP4769194B2 (zh)
KR (1) KR101142074B1 (zh)
CN (1) CN100391935C (zh)
AT (1) ATE369331T1 (zh)
AU (1) AU2004295043B2 (zh)
BR (1) BRPI0416842B8 (zh)
CA (1) CA2546962C (zh)
CY (1) CY1106930T1 (zh)
DE (1) DE602004008103T2 (zh)
DK (1) DK1687259T3 (zh)
ES (1) ES2291982T3 (zh)
HK (1) HK1097512A1 (zh)
IL (1) IL175847A (zh)
NO (1) NO335826B1 (zh)
NZ (1) NZ547393A (zh)
PL (1) PL1687259T3 (zh)
PT (1) PT1687259E (zh)
RU (1) RU2372325C2 (zh)
SI (1) SI1687259T1 (zh)
WO (1) WO2005054178A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007135036A1 (en) * 2006-05-18 2007-11-29 Boehringer Ingelheim International Gmbh METHOD OF PREPARING CHIRAL CYCLIC ß-AMINOCARBOXAMIDES
WO2009080470A1 (en) * 2007-12-19 2009-07-02 Newron Pharmaceuticals S.P.A. Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU177576B (en) * 1975-06-02 1981-11-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing 2-amino-cyclohexane carboxylic acid,its amides and similar compounds
US5532254A (en) * 1995-06-07 1996-07-02 Eli Lilly And Company Modulation of calcium channels using benzothiophenes
JP4160136B2 (ja) * 1996-08-29 2008-10-01 武田薬品工業株式会社 縮合環状エーテル類、その製造法および剤
GB9727523D0 (en) * 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
TWI283577B (en) * 1999-10-11 2007-07-11 Sod Conseils Rech Applic Pharmaceutical composition of imidazole derivatives acting as modulators of sodium channels and the use thereof
DE60219687T2 (de) * 2001-12-27 2007-12-27 Ortho-Mcneil Pharmaceutical, Inc. Aroylpyrrolheteroeryl und methanole zur behandlung von störungen des zentralnervensystems

Also Published As

Publication number Publication date
NO20062352L (no) 2006-05-23
EP1687259A1 (en) 2006-08-09
KR101142074B1 (ko) 2012-05-03
CY1106930T1 (el) 2012-09-26
RU2006117774A (ru) 2007-11-27
ES2291982T3 (es) 2008-03-01
KR20060120138A (ko) 2006-11-24
NZ547393A (en) 2009-12-24
BRPI0416842B8 (pt) 2021-05-25
DE602004008103T2 (de) 2008-04-24
RU2372325C2 (ru) 2009-11-10
CN1886366A (zh) 2006-12-27
IL175847A0 (en) 2006-10-05
US7265244B2 (en) 2007-09-04
US20070066688A1 (en) 2007-03-22
BRPI0416842B1 (pt) 2018-07-31
HK1097512A1 (en) 2007-06-29
ATE369331T1 (de) 2007-08-15
CA2546962C (en) 2012-10-02
PT1687259E (pt) 2007-11-07
WO2005054178A1 (en) 2005-06-16
CA2546962A1 (en) 2005-06-16
JP2007512272A (ja) 2007-05-17
IL175847A (en) 2011-03-31
JP4769194B2 (ja) 2011-09-07
BRPI0416842A (pt) 2007-02-13
AU2004295043A1 (en) 2005-06-16
CN100391935C (zh) 2008-06-04
SI1687259T1 (sl) 2007-12-31
EP1687259B1 (en) 2007-08-08
NO335826B1 (no) 2015-02-23
AU2004295043B2 (en) 2009-06-18
EP1533295A1 (en) 2005-05-25
DE602004008103D1 (en) 2007-09-20
PL1687259T3 (pl) 2008-01-31

Similar Documents

Publication Publication Date Title
DK0956855T3 (da) Immunhæmmende effekter af 8-substituerede xanthin-derivater
IN266803B (zh)
CY1119787T1 (el) Υποκατεστημενα παραγωγα 2-[2-(φαινυλ)αιθυλαμινο] αλκαναμιδιου και η χρηση αυτων ως τροποποιητων του διαυλου νατριου και/ή ασβεστιου
IL175848A0 (en) N - acyl - n' - benzyl - alkylendiamino derivatives
CY1118033T1 (el) Φθοριωμενα παραγωγα αρυλαλκυλαμινοκαρβοξαμιδιου
NO20062352L (no) Cyklopentylderivater
CY1108359T1 (el) Παραγωγα 3-αμινοπυρρολιδονης
ATE553099T1 (de) Substituierte benzylaminoalkylenheterocyclen
SE0400440D0 (sv) Novel Cinnamic Amides
FI914219A0 (fi) 3-(1h-indazol-3-yl)-4-pyridinaminer, foerfarande och mellanprodukter foer deras framstaellning och deras anvaendning som laekemedel.
FR2903698B1 (fr) Nouveaux derives de 5-thioxylopyranose.
WO2005110406A3 (en) Phenyl derivatives for the treatment of abnormal cell growth